Association between inappropriateness of left ventricular mass and left ventricular diastolic dysfunction: A study using the tissue Doppler parameter, E/E'

Korean Circulation Journal

Volumn 39, Issue 4, 2009, Pages 138-144

  Lim, Young Hyo ^a   Lee, Jae Ung ^a   Kim, Kyung Soo ^a   Kim, Soon Gil ^a   Kim, Jeong Hyun ^a   Lim, Heon Kil ^a   Lee, Bang Hun ^a   Shin, Jinho ^a  

^a Hanyang University College of Medicine   (South Korea)

Author keywords

Echocardiography; Hypertrophy; Left ventricle

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE;

EID: 65649123866     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2009.39.4.138     Document Type: Article

References (26)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.
2. de Simone G, Devereux RB, Kimball TR, et al. Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension 1998;31:1077-82.
3. de Simone G, Verdecchia P, Pede S, Gorini M, Maggioni AP. Prognosis of inappropriate left ventricular mass in hypertension. Hypertension 2002;40:470-6.
4. Palmieri V, de Simone G, Roman MJ, Schwartz JE, Pickering TG, Devereux RB. Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass. Hypertension 1999;34:1032-40.
5. de Simone G, Pasanisi F, Contaldo F. Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension 2001;38:13-8.
6. Celentano A, Palmieri V, Esposito ND, et al. Inappropriate left ventricular mass in normotensive and hypertensive patients. Am J Cardiol 2001;87:361-3, A10.
7. de Simone G, Kitzman DW, Palmieri V, et al. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction. Am J Hypertens 2004;17:828-33.
8. World Health Organization. Physical status: the use and interpretation of anthropometry. World Health Organ Tech Rep Ser 1995; 854:1-452.
9. Inoue S, Zimmet P. The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications Australia Pty Limited Sydney 2000;2:5-21.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
11. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy. comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
12. Sohn DW, Choi YJ, Oh BH, Lee MM, Lee YW. Estimation of left ventricular end-diastolic pressure with the difference in pulmonary venous and mitral A durations is limited when mitral E and A waves are overlapped. J Am Soc Echocardiogr 1999;12: 106-12.
13. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002;105:595-601.
14. Shin J, Kim KS, Kim SK, et al. Influences of body size and cardiac workload on the left ventricular mass in healthy Korean adults with normal body weight and blood pressure. Korean Circ J 2005;35:335-40.
15. Conrady AO, Rudomanov OG, Zaharov DV, et al. Prevalence and determinants of left ventricular hypertrophy and remodelling patterns in hypertensive patients. Blood Press 2004;13:101-9.
16. Devereux RB, Dahlof B, Gerdts E, et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol. Circulation 2004;110:1456-62.
17. Racette SB, Evans EM, Weiss EP, Hagberg JM, Holloszy JO. Abdominal adiposity is a stronger predictor of insulin resistance than fitness among 50-95 year olds. Diabetes Care 2006;29:673-8.
18. Price GM, Uauy R, Breeze E, Bulpitt CJ, Fletcher AE. Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death. Am J Clin Nutr 2006;84:449-60.
19. Ix JH, Shlipak MG, Chertow GM, Ali S, Schiller NB, Whooley MA. Cystatin C, left ventricular hypertrophy, and diastolic dysfunction. J Card Fail 2006;12:601-7.
20. Ferrara LA, Vaccaro O, Cardoni O, Laurenzi M, Mancini M, Zanchetti A. Indexation criteria of ventricular mass and predictive role of blood pressure and body composition. Am J Hypertens 2005;18:1282-7.
21. De Sutter J, De Backer J, van de Veire N, Velghe A, De Buyzere M, Gillebert TC. Effects of age, gender and left ventricular mass on septal mitral annulus velocity (E') and the ratio of transmitral early peak velocity to E' (E/E'). Am J Cardiol 2005;95:1020-3.
22. Rovner A, de las Fuentes L, Waggoner AD, Memon N, Chohan R, Dávila-Román VG. Characterization of left ventricular diastolic function in hypertension by use of Doppler tissue imaging and color M-mode techniques. J Am Soc Echocardiogr 2006;19: 872-9.
23. Ahn HS, Kim SJ, Kim MK, et al. The difference of left ventricular hypertrophy and diastolic function between prehypertensives and normotensives. Korean Circ J 2006;36:437-42.
24. Cho KI, Park JH, Lee CK, et al. Isolated and combined influences of diabetes and hypertension on the myocardial function and geometry. Korean Circ J 2006;36:411-7.
25. Kim MH, Kim MK, Choi BY, Shin YJ. Prevalence of the metabolic syndrome and its association with cardiovascular diseases in Korea. J Korean Med Sci 2004;19:195-201.
26. Lee SY, Park HS, Kim DJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007;75:72-80.